Molecular Neurobiology Student Manuscripts

Neurochemistry

• (784)
• THE 5-HT2C RECEPTOR’S EFFECTS ON PENILE ERECTION AND IMPLICATIONS FOR SSRIS (83)
• ABSINTHE (877)
• ACETYLCHOLINE RECEPTOR (612)
• THE ACTION OF MELATONIN IN ALCOHOL WITHDRAWAL (309)
• AGE RELATED CHANGES IN NEUROCHEMISTRY AND NEUROBIOLOGY (384)
• ANALYSIS OF DRUG AND FOOD REWARD AND REINFORCEMENT (362)
• ANTIHISTAMINES FOR TREATMENT OF ALLERGIC RHINITIS (698)
• ASCENDING JACOB'S LADDER: THE HISTORY, NEUROPHARMACOLOGY, AND CURRENT IMPLICATIONS OF THE CHEMICAL WARFARE INCAPACITANT QUINUCLIDINYL BENZILATE (BZ) (15)
• ASTHMA AND ITS PHARMACOLOGIC DRUGS IN TREATMENT (733)
• AYAHUASCA (632)
• THE BIOLOGICAL DANGERS OF FEN-PHEN AND SUBSEQUENT (601)
• THE BIOLOGICAL ROLE OF FREE RADICALS: NITRIC OXIDE (12)
• CAPSAICIN (297)
• CAPSAICIN AND THE PAIN PATHWAY (331)
• CAPSAICIN CAUSES CELL DEATH (186)
• CAPSAICIN: NEUROPATHIC PAIN RELIEVING EFFECT AND NEUROTOXIC EFFECT (305)
• CAPSAICIN: AN OVERVIEW (209)
• CASE STUDIES AND ISSUES REVOLVING AROUND SEROTONERGIC FUNCTION (526)
• THE CELLULAR MECHANISM OF CAPSAICIN AND ITS ROLE AS AN EXCITATORY NEUROTOXIN (53)
• CHILI PEPPERS:A VALUE WORTH TAKING (642)
• CHOCOLATE CRAVING AND THE PHARMACOLOGICAL IMPLICAT (869)
• CHOCOLATE NEUROCHEMISTRY (303)
• COMPLICATIONS OF ALCOHOL WITHDRAWAL (128)
• A CONSIDERATION FOR THE POSSIBLE ROLE OF THE HYPOT (865)
• THE DEATH OF AN ATHLETE: A CASE OF ETHICS, MALPRACTICE, AND CONCEALMENT (511)
• THE DEATH OF DIET DRUGS? (827)
• DIET AND ITS EFFECTS ON THE BRAIN (241)
• DO WE POISON OURSELVES BY EATING CHILI PEPPERS? (130)
• THE EFFECT OF PHOSPHORLATED PROTEINS ON LONG TERM0 (469)
• ELECTRICAL STIMULATION THERAPY (673)
• ENDOGENOUS OPIOID PEPTIDE RESPONSES INDUCED BY EXERCIE AND PHYSICAL ACTIVITY (968)
• GENERAL ANESTHESIA: NEURO-CHEMICAL CORRELATES OF CONSCIOUSNESS? (142)
• GHB- A CURRENT LOOK AT PHARMACOLOGY, CHEMISTRY, AND POLITICS (143)
• GINSENG'S ACTIVITY ON NEUROTRANSMITTER SYSTEMS (221)
• GLUTAMATE: THE MULTI-TALENTED NEUROTRANSMITTER (342)
• GREAT HORMONE AT BEDTIME OR GREVIOUS BODILY HARM (536)
• HYPOTHESIS FOR SEROTONERGIC NEUROTOXICITY AS AN... (281)
• AN INVESTIGATIVE LOOK AT THE POSSIBLE USES OF R(-) (400)
• LEPTIN AND NEUROPEPTIDE Y ON SATIETY & FEEDING (192)
• THE LEPTIN PATHWAY: A REVIEW OF POSSIBLE THERAPEU (773)
• THE MANY FACES OF NITRIC OXIDE (638)
• THE NEUROCHEMISTRY OF CAPSAICIN (806)
• NEUROLOGICAL EFFECTS OF CROTALUS RATTLESNAKE VENOM (713)
• NEUROTOXICITY OF LEAD (388)
• NICOTINE (768)
• NICOTINE ADDICTION: THE HARMFUL AND BENEFICIAL EFFECTS (969)
• NITROUS OXIDE AND ITS ELUSIVE METHOD OF ACTION (908)
• NON-STEROIDAL ANIT-INFLAMMATORY DRUGS: (28)
• AN OVERVIEW OF TETRODOTOXIN (136)
• THE POTENTIAL FOR USE OF HYPERICUM PERFORATUM AS A (43)
• THE POWERFUL PLACEBO (101)
• PROZAC: DRUG OF THE 90S (175)
• PSYCHOLOGICAL AND PHYSIOLOGICAL CONSEQUENCES OF NONCOMPETITIVE ANTAGONISM OF THE NMDA RECEPTOR BY KETAMINE (819)
• PYRIDOSTIGMINE AND THE BRAIN: APPLICATIONS TO PERS (979)
• PYRIDOSTIGMINE BROMIDE, ITS FRIENDS, AND GULF WAR ILLNESS (203)
• RECENT DEVELOPMENTS IN SEROTONIN RECEPTOR TYPE II (440)
• RED HOT CHILIES, FUTURE OF MEDICINE: MYTH OR REAL? (640)
• THE RELATIONSHIP BETWEEN CAPSAICIN AND IT'S INTERA (559)
• A REVIEW OF LEAD'S EFFECTS ON THE HUMAN NERVOUS SYSTEM (397)
• THE REVOLUTIONARY PLACEBO: CONTEMPORARY EVIDENCE OF PLACEBO ANALGESIA AND PLACEBO RESPIRATORY DEPRESSANT RESPONSE MEDIATED VIA OPIOID RECEPTORS AND NONOPIOID RECEPTORS (473)
• ROHYPNOL - (C16H12FN3O3) (523)
• THE ROLE OF SEROTONIN IN SLEEP (179)
• THE SEARCH FOR THE PERMANENT OFF SWITCH (916)
• SELEGILINE (621)
• ST. JOHN'S WORT (65)
• TAKE TWO AND CALL ME IN THE MORNING: THE MECHANISM OF PAIN RELIEF OF NON-STEROID ANTI-INFLAMMATORY DRUGS (NSAIDS) (837)
• THE (296)
• THE EFFECTS OF CAPSAICIN ON PRIMARY AFFERENT NOCIC (416)
• THE USE OF NEUROLEPTICS AND THE EMERGENCE OF TARDIVE DYSKINESIA (741)
• THE VANILLOID RECEPTOR (112)
• WHAT IS GHB?: INFORMATION REGARDING THE HISTORY AND BIOCHEMISTRY OF GAMMA-HYDROXYBUTYRATE (82)

Neurobiology

• AUTISM: NEUROBIOLOGY AND APPROACHES TO TREATMENT (383)
• G PROTEIN (498)
• LONG TERM POTENTIATION AND THE POSSIBILITY THAT IT (59)
• MIGRAINE. A NEUROLOGICAL DISORDER: SYMPTOMS, CAUSE (225)
• MIGRAINES, ARE THEY ALL IN YOUR HEAD? (106)
• MULTIPLE SCLEROSIS: OVERVIEW AND TREATMENTS (36)
• NEURAL MECHANISMS OF MEMORY AND LONG-TERM POTENTIATIN (881)
• THE NEUROBIOLOGICAL CAUSES AND RISK FACTORS INVOLVED IN BIPOLAR DISORDER (292)
• NEUROBIOLOGY OF BIPOLAR AFFECTIVE DISORDER (666)
• NEUROBIOLOGY OF LITHIUM IN THE TREATMENT OF BPAD (788)
• PAIN AND ITS RELATIONSHIP TO MEMORY (104)
• SPECULATIONS ON A VISUAL-LIMBIC SYSTEM (927)
• STRESS AND THE PERMEABILITY OF THE BLOOD-BRAIN BARRIER (146)
• SYNESTHESIA TODAY: AN INTERDISCIPLINARY APPROACH (602)
• TRANSCRANIAL MAGNETIC STIMULATION:AN EXAMINATION.. (54)
• TRAUMA AND BODY (476)
• USING PREPULSE INHIBITION AND MICRO-ARRAY ANALYSIS (802)

Mental Health

• ACTIVATION OF HPA AXIS IN DEPRESSION (348)
• ALTERNATIVE TREATMENTS TO PARKINSON'S DISEASE (818)
• ALZHEIMER'S DISEASE (931)
• ALZHEIMER'S DISEASE - A DISEASE WITHOUT A CURE (838)
• ALZHEIMER'S EXPOSED (222)
• ALZHEIMER’S DISEASE & ALTERNATIVE THERAPIES (495)
• ALZHEIMER’S DISEASE AND ITS RELATIONSHIP WITH MEMORY SYSTEM (900)
• ANOREXIA NERVOSA: ETIOLOGY AND TREATMENT (652)
• ANTIDEPRESSANT-INDUCED SEXUAL SIDE EFFECTS (684)
• THE ANTIDEPRESSIVE EFFECTS OF EXERCISE (512)
• ARE ANTIDEPRESSANTS THE SUPERIOR TREATMENT? (935)
• AS GOOD AS IT GETS? EXPLORING THE CAUSES OF AND PHARMACOLOGICAL TREATMENTS FOR OBSESSIVE-COMPULSIVE DISORDER (44)
• ATTENTION DEFICIT HYPERACTIVITY DISORDER(622)
• BEHAVIORAL ASPECTS AND TREATMENT OF DEPRESSION (660)
• BIPOLAR DISORDER AND WOMEN (341)
• BIPOLAR DISORDER: DISEASE, TREATMENTS, AND TESTING (862)
• BRAIN TISSUE TRANSPLANTATION & PARKINSON'S DISEASE (517)
• CATECHOLAMINES AND DEPRESSION (359)
• CHOLINESTERASE INHIBITORS IN ALZHEIMER'S DISEASE : UNFULFILLED PROMISE OR FUTILE FUTURE? (29)
• THE COMORBIDITY OF DEPRESSION AND MIGRAINE (809)
• COMPUTER USAGE AND DEPRESSION (716)
• CONCERNS ABOUT SSRIS' THERAPY: SIDE EFFECTS, ETC.0 (639)
• CONTROVERSY SURROUNDING ATTENTION DEFICIT DISORDER (159)
• CREATIVITY AND BIPOLAR DISORDER (551)
• CURRENT TREATMENTS AND RESEARCH FOR ALZHEIMER'S DISEASE (568)
• CURRENT TREATMENTS FOR ALZHEIMER'S DISEASE (402)
• DEPRENYL AND ITS EFFECTS IN PATIENTS DIAGNOSED WITH PARKINSONS'S DISEASE (944)
• DEPRENYL:ITS ABILITY TO STUNT THE AGING PROCESS AND THE NEURODEGENERATIVE EFFECTS OF ALZHEIMER'S DISEASE (185)
• DEPRENYL’S BROAD PHARMACOLOGICAL ACTIVITY (663)
• DEPRESSION (524)
• DEPRESSION & CURRENT TREATMENTS (558)
• DEPRESSION - ITS NATURE, HISTORICAL PERCEPTION, SIGNS AND SYMPTOMS, AND PREVENTATIVE MEASURES. (52)
• DOPAMINERGIC SYSTEMS: A LINK BETWEEN SCHIZOPHRENIA AND STIMULANT-INDUCED PSYCHOSIS? (261)
• EFFECTS OF ALCOHOL:ENZYME DEFICIENCY AND ALCOHOLISM (298)
• EFFECTS OF COCAINE AND ALCOHOL CONSUMPTION. (314)
• THE EFFECTS OF MDMA (ECSTASY) ON THE SEROTONERGIC NEURONS OF THE BRAIN (736)
• THE EFFECTS OF SCHIZOPHRENIA ON SOCIAL FUNCTIONING (534)
• ESTROGEN AND ALZHEIMER'S DISEASE (294)
• EXPLORING THE LINK BETWEEN CAFFEINE WITHDRAWAL SYMPTOMS AND THE NEUROCHEMICAL CHANGES CAUSED BY REGULAR CAFFEINE CONSUMPTION (861)
• EXTRACTS OF HYPERICUM PERFORATUM AS ANTIDEPRESSANTS: A REVIEW OF RECENT REPORTS (387)
• THE GENDER DISCREPANCY IN DEPRESSION (490)
• THE GENETICS AND NEUROCHEMISTRY ASSOCIATED WITH TS (365)
• HOW PARKINSON'S DISEASE WORKS (181)
• HUNTINGTOS DISEASE AND BASAL GANGLIA (868)
• HYPERTENSION (279)
• THE INNOVATION AND POWER OF TREATMENTS FOR MAJOR DEPRESSION (644)
• INVESTIGATING SCHIZOPHRENIA: A DISEASE OF THE SOCIETY (746)
• LITHIUM ACTION MECHANISMS IN THE TREATMENT OF MANIC DEPRESSION (751)
• LITHIUM MAINTENANCE THERAPY FOR MANIA: PRO VS. CON (16)
• LITHIUM'S EFFECTS ON BIPOLAR DISEASE (422)
• A LOOK AT EATING DISORDERS: ANOREXIA NERVOSA AND BULIMIA NERVOSA (459)
• MAJOR DEPRESSION: DIFFERENT VIEWS AND TREATMENTS (291)
• MANIC DEPRESSION: A GIFT OF THE CREATIVE (856)
• MANIC DEPRESSIVE ILLNESS: NEW TREATMENTS, NEW PERS (132)
• NARCOLEPSY...A SLEEPING DISEASE (267)
• NATUAL SUPPLEMENTS & HERBS AND ALZHEIMER'S (876)
• NEUROPROTECTIVE ACTIVITY OF ESTROGEN IN ALZHEIMER'S DISEASE (999)
• THE NEUROSCIENCE BEHIND ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD) (262)
• NUTRITIONAL FACTORS : NATURAL TREATMENT FOR DEPRESSION (9)
• OBESITY, ITS CAUSES, AND PHARMACOLOGICAL TREATMENT ALTERNATIVES (691)
• OBSESSIVE COMPULSIVE DISORDER (22)
• OBSESSIVE-COMPULSIVE DISORDER: NEW HYPOTHESES IN ETIOLOGY AND BREAKTHROUGH TREATMENT APPROACHES (458)
• OLD FOLKS LOSING THEIR MIND (5)
• AN OVERVIEW OF BIPOLAR DISORDER AND ITS TREATMENT (510)
• OXIDATIVE STRESS IN PARKINSON'S DISEASE (412)
• PALLIDOTOMY: TREATMENT FOR PARKINSON'S DISEASE (624)
• PARKINSON'S DISEASE2 (572)
• PARKINSON'S DISEASE: AN OVERVIEW OF DEVELOPING TH (991)
• PARKINSON'S DISEASE: CURRENT AND FUTURE TREATMENTS (519)
• PHARMACOLOGICAL INTERVENTIONS FOR CHILDREN AND ADOLESCENTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD): THE CASE OF RITALIN (39)
• PHARMACOLOGY TREATMENT OF DEPRESSION (967)
• PSYCHOLOGICAL THERAPY VS. ANTIDEPRESSANT DRUG THERAPY FOR MAJOR DEPRESSION (71)
• RECENT ADVANCES IN THE BIOCHEMICAL CAUSES OF ALZHEIMER'S DISEASE (898)
• SCHIZOPHRENIA: INSIDE AND OUT (681)
• SCHIZOPHRENIA: COGNITIVE IMPAIRMENTS STUDIES AS A (886)
• SCHIZOPHRENIA AND ITS TREATMENT WITH CLOZAPINE (787)
• SEASONAL AFFECTIVE DISORDER (245)
• SEASONAL AFFECTIVE DISORDER: AN UNDERSTANDING OF THIS DISORDER (377)
• SEROTONERGIC MECHANISMS INNOLVED IN THE TREATMENTS OF OBSESSIVE-COMPULSIVE DISORDER (367)
• SEROTONERGIC REGULATION OF OBESITY AND ANTI-OBESITY TREATMENTS (287)
• SEROTONIN EFFECTS ON OBESITY AND EATING DISORDERS (831)
• SJW A CRITICAL LOOK AT THE ANTIDEPRESSANT ACTIVITY (50)
• SUICIDE & SEROTONIN (465)
• SURGERY TREATMENTS FOR THE PARKINSON'S DISEASE (4)
• THE SEARCH FOR AN ENDOGENOUS SCHIZOTOXIN (582)
• TOURETTE'S SYNDROME: A COMPREHENSIVE REVIEW (141)
• TRANSMAGNETIC STIMULATION IN THE TREATMENT OF DEPRESSION (905)
• TREATMENT OF PARKINSON'S DISEASE (576)
• TREATMENTS FOR PARKINSON'S DISEASE (386)
• VALIDITY OF DOPAMINE HYPOTHESIS TO SCHIZOPHRENIA (286)
• WOMEN AND DEPRESSION (401)

Psychoactive Drugs

• BIOLOGICAL AND SOCIAL ASPECTS OF AMPHETAMINE (742)
• THE CANNABINOID RECEPTORS AND IMMUNOSUPPRESSION BY D9 TETRAHYDRACANNABINOL (449)
• CAFFEINE AND ITS PHYSIOLOGICAL EFFECTS (442)
• CAFFEINE: WHAT WE SHOULD KNOW (477)
• CHRONIC COCAINE ABUSE (637)
• CHRONIC EFFECTS OF MARIJUANA ON MEMORY (956)
• A CLOSER LOOK AT MDMA (867)
• COCAINE AND ALCOHOL: EFFECTS MORE PRONOUNCED THAN (468)
• CRACK:INNER CITY DECAY IN AMERICA (85)
• THE CURRENT STATUS OF MARIJUANA RESEARCH (737)
• THE DEBATE OVER MARIJUANA:BENEFICIAL AND DETRIMENT (168)
• DRUGS, SEX AND POLITICS (180)
• ECSTASY AND THE MECHANISMS OF SEROTONIN UPTAKE SITE NEURODEGENERATIONUPTAKE SITE NEURODEGENERATION (472)
• ECSTASY: FRIEND OR FOE (959)
• THE EFFECTS OF TEMPERATURE AND DRUGS ON THE NEUROTOXIC POTENCY OF MDMA (361)
• IBOGAINE:A SPIRITUAL AND MEDICINAL JOURNEY (617)
• IMMUNOMODULATION EFFECTS OF THC (255)
• KETAMINE (962)
• KETAMINE AND THE ENTHEOGENIC TRADITION (513)
• KETAMINE: NEUROCHEMISTRY AND RECREATIONAL USE (596)
• LACK OF RESEARCH AIDS IN MDMA SUBCULTURE EXPLOSION (131)
• LONG-TERM NEUROTOXIC EFFECTS OF MDMA ARE SHOWN.... (542)
• LSD (278)
• LSD AND IT'S MEDICAL USES (352)
• LSD: EFFECTS AND MECHANISMS (575)
• MARIJUANA (895)
• MARIJUANA'S EFFECTS ON MEMORY (8)
• MARIJUANA: THE POLITICS AND POLICIES (75)
• MARIJUANA AND IMMUNE SYSTEM (299)
• MARIJUANA AS A MEDICINE (584)
• MDMA ( (976)
• MDMA -- THE REAL TRUTH (463)
• MDMA: ECSTASY OR NIGHTMARE? (946)
• MDMA: POSITIVE EFFECTS OUTWEIGH THE NEGATIVE (31)
• MDMA: SCIENCE AND POPULAR CULTURE (321)
• MDMA RESEARCH IN RODENTS AND MONKEYS PROVE USELESS (484)
• THE MECHANISM OF NEUROTOXICITY OF MDMA (915)
• MEDICAL MARIJUANA AND CALIFORNIA'S MEDICAL MARIJUA (147)
• THE MEDICINAL USES OF COCA AND MARIJUANA AND THE HYPOCRISY OF WESTERN MEDICINE (86)
• MESCALINE (600)
• METHAMPHETAMINE USE COULD INCREASE THE CHANCE OF G (693)
• MODERN PEYOTISM: ITS NATIVE INFLUENCES AND CONDITIONS FOR ITS DIFFUSION INTO THE UNITED STATES (859)
• NEUROTOXICITY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, “ECSTASY”) (884)
• OPIUM AND ITS SOURCE, THE OPIUM POPPY (672)
• PHYSIOLOGICAL EFFECTS OF COCAINE (480)
• THE POSITIVE AND NEGATIVE EFFECTS OF MARIJUANA: (657)
• PSILOCYBIN AWARENESS (471)
• PSILOCYBIN INDUCES ACUTE/INITIAL STAGE SCHIZOPHREN (405)
• PSILOCYBIN: A SCHEDULE I DRUG? (653)
• PSYCHEDELICS AND PSYCHOSIS:THE DMT MODEL OF SCHIZO (391)
• A REVIEW OF MDMA (762)
• SMART DRUGS: ENHANCING COGNITIVE FUNCTION WITH PIRACETAM (774)
• SMOKING, IT'S PHYSIOLOGICAL EFFECTS, AND NICOTINE WITHDRAWAL (971)
• SUDDEN DEATH IN ATHLETES RELATED TO COCAINE AND IT (265)
• THE SOLUTION TO AMERICA'S DRUG PROBLEM: A HALLUCINOGEN? (272)
• TOAD VENOM...THEIR TOXICITY & PSYCHOACTIVE EFFECTS (515)
• TREATMENTS OF OPIATE ADDICTION: CURRENT TECHNIQUES AND STUDIES WITH IMPLICATIONS FOR FUTURE TREATMENTS (325)
• THE USE OF LSD IN THE TREATMENT OF ALCOHOLISM (49)
• THE USES AND PSYCHOACTIVE PROPERTIES OF DEXTROMETHORPHAN (67)
• VISIONS PRODUCED BY DREAMING AND ENTHEOGENIC DRUGS (794)

Historical

• A BRIEF HISTORY AND OVERVIEW OF TETRODOTOXIN (TTX) (317)
• THE HISTORY AND FUTURE OF ENDORPHINS IN DEPRESSION (467)
• THE HISTORY AND PSYCHOACTIVITY OF BUFO TOADS (912)
• NATIVE AMERICANS AND ALCOHOLISM (320)
• OPIUM: WHAT ANCIENT CIVILIZATIONS ALREADY KNEW (18)
• PRIMATES AND PRIMITIVE UNDERSTANDING OF MEDICINE (948)
• RITUAL ORIGINS OF ENTHEOGENIC DRUGS (945)

Miscellaneous

• ACUPUNCTURE AND EXERCISE: A STUDY OF THE RELATIONS (925)
• ACUPUNCTURE: A PROMISING TREATMENT FOR DEPRESSION (805)
• APHRODISIACS:THEIR BIOLOGICAL BASIS (98)
• FOOD AND THE BRAIN - THE EFFECTS OF NUTRITION ON EMOTIONAL AND MENTAL HEALTH (980)
• FOOD AND ITS EFFECTS ON MOOD AND BEHAVIOR (901)
• FOOD MOOD CONNECTION (432)
• THE GULF WAR SYNDROME:ORGANOPHOSPHATE INDUCED NEUROTOXICITY (456)
• HEAD INJURY, CONCUSSSION (109)
• HOW FAST DOES YOUR REALITY GO? (987)
• THE LIVED EXPERIENCE OF PAIN: DILEMMAS IN STUDY AND PRACTICE (628)
• MA HUANG, AN OLD DRUG WITH NEW PROBLEMS (200)
• NEAR DEATH EXPERIENCES (97)
• NEUROPATHOLOGY AND SOCIOLOGY OF BOXING (164)
• OVERVIEW OF ORGANOPHOSPHATE NERVE AGENTS (543)
• PENICILLIN FOR THE SOUL (687)
• THE PHYSIOLOGICAL BENEFITS OF LAUGHTER (116)
• THE PHYSIOLOGY OF PAIN AND ITS TREATMENT (804)
• PMS (433)
• RUNNER'S HIGH: FACT OR FICTION? (839)
• SPORTS AND AMPHETAMINES (435)
• WILL SERBIAN TANKS OR AMERICAN ORGANOPHOSPHOSPHATE (815)

Back